Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Buy
43,247
+5,997
+16% +$400K 0.05% 391
2026
Q1
$2.34M Buy
37,250
+4,636
+14% +$323K 0.05% 411
2025
Q4
$2.16M Buy
32,614
+13,815
+73% +$893K 0.04% 419
2025
Q3
$1.26M Buy
18,799
+14,699
+359% +$1.16M 0.03% 523
2025
Q2
$358K Sell
4,100
-167
-4% -$13.1K 0.01% 855
2025
Q1
$291K Sell
4,267
-1,028
-19% -$83.9K 0.01% 832
2024
Q4
$412K Buy
+5,295
New +$392K 0.02% 705
2024
Q3
Sell
-1,881
Closed -$213K 1002
2024
Q2
$213K Buy
1,881
+38
+2% +$4.8K 0.01% 891
2024
Q1
$256K Buy
1,843
+81
+5% +$10.2K 0.01% 775
2023
Q4
$219K Sell
1,762
-1,267
-42% -$129K 0.01% 812
2023
Q3
$283K Sell
3,029
-205
-6% -$23.1K 0.02% 639
2023
Q2
$416K Sell
3,234
-413
-11% -$50K 0.04% 472
2023
Q1
$424K Buy
3,647
+196
+6% +$21.9K 0.03% 531
2022
Q4
$391K Sell
3,451
-1,052
-23% -$115K 0.04% 473
2022
Q3
$362K Buy
4,503
+553
+14% +$46.8K 0.01% 484
2022
Q2
$294K Buy
3,950
+406
+11% +$37.1K 0.04% 471
2022
Q1
$453K Buy
3,544
+212
+6% +$23.2K 0.05% 390
2021
Q4
$447K Buy
3,332
+128
+4% +$18.4K 0.05% 398
2021
Q3
$499K Buy
3,204
+276
+9% +$34.8K 0.06% 341
2021
Q2
$313K Buy
+2,928
New +$281K 0.04% 437
2019
Q1
Sell
-252
Closed -$7K 713
2018
Q4
$7K Buy
+252
New +$7.99K ﹤0.01% 1242
2018
Q1
$3K Hold
176
﹤0.01% 1433
2017
Q4
$3K Buy
+176
New +$2.29K ﹤0.01% 1427

Other funds holding DXCM

MGO One Seven's DXCM Position: Q2 2026 in Review

MGO One Seven increased its DexCom (DXCM) stake by 16% in Q2 2026, buying an estimated $400K and bringing the position to 43,247 shares worth $2.91M. The position accounts for 0.05% of the portfolio, ranked #391.

MGO One Seven first reported a position in DXCM in Q4 2017 and has held it in 23 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • MGO One Seven held 43,247 shares of DexCom worth $2.91M as of Q2 2026.
  • MGO One Seven bought 5,997 DexCom shares in Q2 2026, an estimated $400K.
  • DexCom made up 0.05% of MGO One Seven's portfolio in Q2 2026, its #391 holding.
  • MGO One Seven first reported a position in DexCom in Q4 2017 and has held it in 23 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.